L. Tanajura

Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.

J. E. Sousa, R. Costa, F. Feres, 2008, JACC. Cardiovascular interventions.

EXCELLA First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions.

P. Fitzgerald, J. E. Sousa, R. Costa, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel‐tantalum‐stainless steel phosphorylcholine‐coated stent: The TriMaxx trial

J. Popma, F. Feres, A. Abizaid, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.

P. Fitzgerald, A. Lansky, F. Feres, 2007, American Journal of Cardiology.

[Comparative analysis of intimal hyperplasia after sirolimus-eluting stent and thin-strut bare-metal stent implantation in small coronary arteries].

F. Feres, A. Abizaid, Fernando S Devito, 2006, Arquivos brasileiros de cardiologia.

Correlation between Plaque Composition as assessed by Virtual Histology and C-reactive Protein

F. Feres, A. Abizaid, R. Staico, 2013, Arquivos brasileiros de cardiologia.